FNI1 Stock Overview
Fosun International Limited operates in the health, happiness, wealth, and intelligent manufacturing sectors in Mainland China, Portugal, and internationally.
| Snowflake Score | |
|---|---|
| Valuation | 3/6 |
| Future Growth | 4/6 |
| Past Performance | 0/6 |
| Financial Health | 2/6 |
| Dividends | 3/6 |
Rewards
Risk Analysis
Fosun International Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | HK$17.20 |
| 52 Week High | HK$24.60 |
| 52 Week Low | HK$13.80 |
| Beta | 1 |
| 1 Month Change | 0% |
| 3 Month Change | -3.37% |
| 1 Year Change | -23.89% |
| 3 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | -38.25% |
Recent News & Updates
Recent updates
Shareholder Returns
| FNI1 | DE Industrials | DE Market | |
|---|---|---|---|
| 7D | 0% | -1.7% | -2.0% |
| 1Y | -23.9% | 18.3% | -0.3% |
Return vs Industry: FNI1 underperformed the German Industrials industry which returned 20.5% over the past year.
Return vs Market: FNI1 underperformed the German Market which returned 5.9% over the past year.
Price Volatility
| FNI1 volatility | |
|---|---|
| FNI1 Average Weekly Movement | n/a |
| Industrials Industry Average Movement | 4.2% |
| Market Average Movement | 4.8% |
| 10% most volatile stocks in DE Market | 10.0% |
| 10% least volatile stocks in DE Market | 2.4% |
Stable Share Price: FNI1 has not had significant price volatility in the past 3 months.
Volatility Over Time: Insufficient data to determine FNI1's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1992 | 106,000 | Qiyu Chen | www.fosun.com |
Fosun International Limited operates in health, happiness, wealth, and intelligent manufacturing sectors in Mainland China, Portugal, and internationally. It operates in five segments: Health, Happiness, Insurance, Asset Management, and Intelligent Manufacturing. The Health segment engages in the research, development, manufacture, sale, and trading of pharmaceutical, biopharmaceutical, and health products; and provision of medical and health management services.
Fosun International Limited Fundamentals Summary
| FNI1 fundamental statistics | |
|---|---|
| Market cap | €6.36b |
| Earnings (TTM) | €1.20b |
| Revenue (TTM) | €23.69b |
5.3x
P/E Ratio0.3x
P/S RatioIs FNI1 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| FNI1 income statement (TTM) | |
|---|---|
| Revenue | CN¥173.74b |
| Cost of Revenue | CN¥114.43b |
| Gross Profit | CN¥59.31b |
| Other Expenses | CN¥50.54b |
| Earnings | CN¥8.77b |
Last Reported Earnings
Jun 30, 2022
Next Earnings Date
n/a
| Earnings per share (EPS) | 1.07 |
| Gross Margin | 34.14% |
| Net Profit Margin | 5.05% |
| Debt/Equity Ratio | 138.7% |
How did FNI1 perform over the long term?
See historical performance and comparison